Top Markets
#1 EXOD EXOD +56.80%
#2 Arowana Arowana +8.48%
#3 Harmony Harmony +7.27%
#4 Fake World Assets Fake World Assets +6.48%
#5 Cysic Cysic +5.83%
#6 Orochi Network Orochi Network +3.92%
#7 Dual Dual +3.59%
#8 Fabric Protocol Fabric Protocol +3.54%
#9 Figure Heloc Figure Heloc +3.49%
#10 TAGGER TAGGER +3.35%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Classificação em ações #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Preço da ação
$0.00953895
Última sincronização: 2024-05-22
Valor de mercado
$1.28M
Variação (1 dia)
0.06%
Variação (1 ano)
0.00%
País
GB
Negociar Evgen Pharma plc (EVG)

Categoria

Healthcare
Lucros da Evgen Pharma plc (EVG)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Evgen Pharma plc, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Evgen Pharma plc de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE